HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Swen M John Selected Research

Skin Diseases (Skin Disease)

10/2021Treatment with alitretinoin in patients taking part in a tertiary individual prevention program for work-related skin diseases.
12/2020Effectiveness of secondary prevention in metalworkers with work-related skin diseases and comparison with participants of a tertiary prevention program: A prospective cohort study.
9/2020Tape stripping the stratum corneum for biomarkers of ultraviolet radiation exposure at sub-erythemal dosages: a study in human volunteers.
6/2020Economic evaluation of a tertiary prevention program for occupational skin diseases in Germany.
1/2019Tertiary prevention of occupational skin diseases: Prevalence of allergic contact dermatitis and pattern of patch test results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Swen M John Research Topics

Disease

10Contact Dermatitis (Eczema, Contact)
07/2023 - 05/2008
8Eczema
01/2024 - 10/2012
8Hypersensitivity (Allergy)
02/2023 - 04/2014
5Dermatitis
01/2023 - 05/2008
5Skin Diseases (Skin Disease)
10/2021 - 01/2019
4Allergic Contact Dermatitis
05/2024 - 07/2017
3Asthma (Bronchial Asthma)
01/2023 - 03/2013
3Inflammation (Inflammations)
04/2012 - 05/2008
2Necrosis
04/2012 - 05/2008
1Allergic Rhinitis
01/2023
1Chromosome Aberrations (Chromosome Abnormalities)
01/2023
1Dyspnea (Shortness of Breath)
10/2022
1Respiratory Sounds (Crackle)
10/2022
1Neoplasms (Cancer)
01/2022
1Atopic Dermatitis (Atopic Eczema)
07/2017
1Thinness
04/2014
1Burnett Schwartz Berberian syndrome
03/2013

Drug/Important Bio-Agent (IBA)

12Irritants (Vesicants)IBA
05/2024 - 05/2008
6AllergensIBA
01/2024 - 04/2014
2Tuberculin (PPD)IBA
02/2023 - 01/2023
2HaptensIBA
01/2023 - 05/2021
2SaltsIBA
01/2023 - 10/2022
2Biomarkers (Surrogate Marker)IBA
09/2020 - 07/2017
2MetalsIBA
06/2020 - 03/2015
2CytokinesIBA
04/2012 - 05/2008
2InterleukinsIBA
05/2008 - 05/2008
1ammonium peroxydisulfateIBA
02/2023
12,5-diaminotolueneIBA
02/2023
12-mercaptoacetate (ammonium thioglycolate)IBA
02/2023
14-phenylenediamine (p-phenylenediamine)FDA Link
02/2023
1Hair Preparations (Cosmetics, Hair)IBA
02/2023
1PowdersIBA
10/2022
1ethyl 2-cyanoacrylate (Krazy glue)IBA
06/2022
1Adhesives (Glues)IBA
06/2022
1AcrylatesIBA
06/2022
1hydroxyethyl methacrylate (HEMA)IBA
06/2022
1mesoglycanIBA
01/2022
1AlitretinoinFDA Link
10/2021
1Interleukin-16 (Interleukin 16)IBA
05/2021
1SodiumIBA
04/2018
1Formaldehyde (Formol)FDA Link
03/2015
1Epoxy ResinsFDA Link
03/2015
1ThiramFDA Link
03/2015
12-methyl-4-isothiazolin-3-oneIBA
03/2015
15-chloro-2-methyl-4-isothiazolin-3-oneIBA
03/2015
1Immunoglobulin E (IgE)IBA
03/2013
1Filaggrin ProteinsIBA
03/2013
1Ointments (Pastes)IBA
05/2008
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2008
1Interleukin-8 (Interleukin 8)IBA
05/2008
1Interleukin-1alpha (Interleukin 1 alpha)IBA
05/2008
1Interleukin-1beta (Interleukin 1 beta)IBA
05/2008
1Interleukin-1 (Interleukin 1)IBA
05/2008
1Tacrolimus (Prograf)FDA LinkGeneric
05/2008
1Interleukin-10 (Interleukin 10)IBA
05/2008

Therapy/Procedure

3Tertiary Prevention
12/2020 - 01/2019
2Secondary Prevention
12/2020 - 10/2012
1Skin Care
04/2014